Intestine‐Targeted Controlled Hydrogen‐Releasing MgH 2 Microcapsules for Improving the Mitochondrial Metabolism of Inflammatory Bowel Disease
In mice, high‐dose oral administration of MgH 2 @EC@ES microcapsules exhibits a high outcome of colitis prevention, which is comparable to the first‐line drug 5‐aminosalicylic acid (5‐ASA) in the changes of body/spleen weights and disease activity and even better in the recovery…
Read Article